DIASORIN S.P.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.18 EUR | +1.79% |
|
+5.17% | -2.21% |
| Apr. 19 | Marble Bar Asset Management cuts short on OVS. | AN |
| Apr. 18 | Marshall Wace moves on Leonardo and OVS. | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc.
At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.
Calendar
2024-04-23
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
91.18
EUR
Average target price
97.41
EUR
Spread / Average Target
+6.83%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.21% | 5.1B | |
| -1.04% | 12.47B | |
| -17.29% | 6.99B | |
| +2.92% | 4.27B | |
| -4.79% | 4.27B | |
| -50.07% | 3.45B | |
| +7.65% | 2.61B | |
| -15.92% | 2.08B | |
| -3.34% | 1.67B | |
| -13.66% | 1.48B |
- Stock Market
- Equities
- DIA Stock
- News DiaSorin S.p.A.
- Italy's DiaSorin Gets US FDA Nod For Simplexa COVID-19 Direct Testing Kit
